Well, thank you, Michael, for the question.
I think it's a combination of all the factors you mentioned. Our screening of substances is not what it should be. Once they're available commercially, our ability to control them is over-rated, and when that occurs our ability to ensure compliance and enforcement is not up to snuff.
I think all of those problems are embedded in CEPA as currently drafted. I'd add it's partially the fault of ineffective provincial environmental laws as well. But when you're talking about a substance as hazardous as 1,4-dioxane, the buck stops with CEPA, and CEPA has not been up to the task, I'm not going to say with respect to this particular chemical, because I'm not that familiar with it, but with respect to the release of toxic substances generally, as some of the data that we've provided to the committee demonstrates.
The levels of releases we are seeing with persistent bioaccumulative and toxic substances in the six-year period since the CMP process came into effect are not a recommendation for maintaining CEPA as currently drafted.